Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FABP12 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | MTRR | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | MLN | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | SYN2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | SAMD1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | NOS1AP | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | FAM189B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | CELF6 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | PCDHA10 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | GPR150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |